Pancreatic cancer: Advances and challenges

CJ Halbrook, CA Lyssiotis, MP di Magliano, A Maitra - Cell, 2023‏ - cell.com
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers. Significant
efforts have largely defined major genetic factors driving PDAC pathogenesis and …

Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy

S Bärthel, C Falcomatà, R Rad, FJ Theis, D Saur - Nature cancer, 2023‏ - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer entity characterized by a
heterogeneous genetic landscape and an immunosuppressive tumor microenvironment …

Epithelial and stromal co-evolution and complicity in pancreatic cancer

SR Hingorani - Nature Reviews Cancer, 2023‏ - nature.com
Pancreatic ductal adenocarcinomas are distinguished by their robust desmoplasia, or
fibroinflammatory response. Dominated by non-malignant cells, the mutated epithelium must …

Spatial landscapes of cancers: insights and opportunities

J Chen, L Larsson, A Swarbrick… - Nature Reviews Clinical …, 2024‏ - nature.com
Solid tumours comprise many different cell types organized in spatially structured
arrangements, with substantial intratumour and intertumour heterogeneity. Advances in …

Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice

B Assouline, R Kahn, L Hodali, R Condiotti… - Nature …, 2024‏ - nature.com
Senescent cells within tumors and their stroma exert complex pro-and anti-tumorigenic
functions. However, the identities and traits of these cells, and the potential for improving …

Single‐cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment

G Cao, J Yue, Y Ruan, Y Han, Y Zhi, J Lu, M Liu… - The EMBO …, 2023‏ - embopress.org
The tumor microenvironment (TME) directly determines patients' outcomes and therapeutic
efficiencies. An in‐depth understanding of the TME is required to improve the prognosis of …

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

W Luo, T Wen, X Qu - Journal of Experimental & Clinical Cancer Research, 2024‏ - Springer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumors. The tumor
immune microenvironment (TIME) formed by interactions among cancer cells, immune cells …

Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment

X Guo, Y Wu, Y Xue, N **e, G Shen - Frontiers in Immunology, 2023‏ - frontiersin.org
Recent progressions in immunotherapy have transformed cancer treatment, providing a
promising strategy that activates the immune system of the patient to find and eliminate …

Single-cell multi-omics analysis of human testicular germ cell tumor reveals its molecular features and microenvironment

X Lu, Y Luo, X Nie, B Zhang, X Wang, R Li… - Nature …, 2023‏ - nature.com
Seminoma is the most common malignant solid tumor in 14 to 44 year-old men. However, its
molecular features and tumor microenvironment (TME) is largely unexplored. Here, we …

[HTML][HTML] Advances in melanoma: from genetic insights to therapeutic innovations

F Valdez-Salazar, LA Jiménez-Del Rio… - Biomedicines, 2024‏ - mdpi.com
Advances in melanoma research have unveiled critical insights into its genetic and
molecular landscape, leading to significant therapeutic innovations. This review explores the …